Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PRQR
Stock Latest News
Stock Analysis & Ideas
Oppenheimer Predicts Up to ~560% Rally for These 2 ‘Strong Buy’ Stocks
4d ago
PRQR
SERV
Premium
Company Announcements
ProQR Sets April 8 Virtual Investor Event to Spotlight Axiomer RNA Editing Pipeline
7d ago
6K
PRQR
Premium
Company Announcements
ProQR Therapeutics Faces Heightened Activist Investor Pressure and Governance Uncertainty
19d ago
PRQR
Premium
Company Announcements
ProQR Posts 2025 Results as Axiomer RNA Editing Pipeline Advances and Cash Runway Extends to Mid-2027
20d ago
6K
PRQR
Premium
The Fly
ProQR Therapeutics assumed with an Outperform at Oppenheimer
20d ago
PRQR
Premium
The Fly
ProQR Therapeutics reports FY25 EPS (EUR 0.40) vs (EUR 0.32) last year
20d ago
PRQR
Premium
The Fly
ProQR Therapeutics participates in a conf call hosted by Cantor Fitzgerald
1M ago
PRQR
Premium
Pre-Earnings
PRQR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
PRQR
Premium
Company Announcements
ProQR Therapeutics Plans Board Changes as Co-Founder and Director Exit at 2026 AGM
2M ago
6K
PRQR
Premium
The Fly
ProQR Therapeutics directors Dinko Valerio, Alison Lawton to depart
2M ago
PRQR
Premium
Company Announcements
ProQR Reports Positive AX-0810 Phase 1 Data, Advances Rett and MASH Candidates, and Outlines 2026 Pipeline Plans
3M ago
6K
PRQR
Premium
The Fly
ProQR announces initial safety, PK data from Phase 1 trial of AX-0810
3M ago
LLY
PRQR
Premium
Ratings
Positive Outlook for ProQR’s AX-0810 in Treating Primary Sclerosing Cholangitis Justifies Buy Recommendation
4M ago
PRQR
Premium
Company Announcements
ProQR Therapeutics Reports Q3 2025 Financial Results
4M ago
PRQR
Premium
Company Announcements
ProQR Reports Q3 2025 Financial Results Amid Revenue Decline
5M ago
6K
PRQR
Premium
The Fly
ProQR Therapeutics reports Q3 (EUR 0.10) vs (EUR 0.10) last year
5M ago
PRQR
Premium
Ratings
ProQR Positioned for Growth: Strategic Advancements and Clinical Milestones in RNA Editing
5M ago
PRQR
Premium
Company Announcements
ProQR Advances AX-0810 into Clinical Trials for Cholestatic Diseases
5M ago
6K
PRQR
Premium
Pre-Earnings
PRQR Upcoming Earnings Report: What to Expect?
5M ago
PRQR
Premium
Company Announcements
ProQR Receives CTA Authorization for AX-0810 and Plans Investor Event
5M ago
6K
PRQR
Premium
The Fly
ProQR Therapeutics receives CTA authorization for AX-0810
5M ago
PRQR
Premium
The Fly
ProQR Therapeutics management to meet with Citizens JMP
6M ago
PRQR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
